AI in Drug Discovery Market to Soar $12.02 Bn by 2032 Driven by Oncology & Deep Learning Innovations

BLOOMFIELD, Conn. - Sept. 26, 2025 - PRLog -- Ameco Research unveils its latest Artificial Intelligence in Drug Discovery Market Report, revealing that the global Artificial Intelligence in Drug Discovery Market was valued at USD 1.35 billion in 2023 and is forecasted to reach USD 12.02 billion by 2032, expanding at a strong compound annual growth rate (CAGR) of 27.8% from 2024 to 2032.

The report offers comprehensive Artificial Intelligence in Drug Discovery Market Analysis, including market drivers, challenges, regional dynamics, technology segmentation, and key players.

Artificial Intelligence in Drug Discovery Market Statistics & Market Share Highlights

• Market Size (2023): USD 1.35 Billion
• Forecasted Market Size (2032): USD 12.02 Billion
• Projected Growth (CAGR 2024–2032): 27.8%
• Largest Therapeutic Area (2023): Oncology – accounted for about 22% share of the market
• Leading Region (2023): North America generated over 55% of total market revenue

Key Trends & Growth Drivers

1. Oncology Leads Demand
   The therapeutic area segment analysis shows oncology as the largest contributor in revenue share in 2023 due to critical need for cancer treatment, rising incidence, and development of novel therapies.
2. Dominance of Machine Learning & Deep Learning
   In the Artificial Intelligence in Drug Discovery Market Trends, machine learning technologies—especially deep learning—lead in market share. These technologies are preferred for modeling, virtual screening, drug-target interaction prediction, and de novo drug design.
3. Broad Technology Applications Across Drug Discovery Phases
   Key segments such as target identification, molecule screening, de novo drug design, and preclinical/clinical testing are all being transformed by AI tools, driving efficiency and reducing costs.
4. Regional Leadership & Investment Patterns
   North America dominates the market share in 2023 with over 55% revenue contribution, thanks to heavy investment in AI and drug discovery by pharma firms and strong public/private collaborations. Asia-Pacific (China, India, and other countries) is also emerging rapidly due to expanding biotech capabilities and favorable regulatory initiatives.

Get Free PDF Sample Report: https://www.amecoresearch.com/sample/277102

Artificial Intelligence in Drug Discovery Market Drivers & Challenges

The Artificial Intelligence in Drug Discovery Market Report identifies major drivers:

• Rising prevalence of chronic and complex diseases
• Need to reduce time and cost of drug development
• Increasing investments in AI platforms and computational biology
• Strategic collaborations between tech giants and pharmaceutical companies

Competitive Landscape & Strategic Opportunities

Leading players profiled in the report include

• Atomwise
• BenevolentAI
• DeepMind (Google)
• Exscientia
• IBM
• NVIDIA
• Insilico Medicine
• Tempus
• Microsoft

Read Full Analysis at Ameco Research: https://www.amecoresearch.com/market-report/artificial-intelligence-in-drug-discovery-market-277102